Jaguar Health (JAGX) Preferred Dividend Payments (2014 - 2026)
Jaguar Health's (JAGX) quarterly Preferred Dividend Payments came in at $6.1 million in Q1 2026, up 264.14% on a QoQ basis from $1.7 million in Q4 2020.
Jaguar Health (JAGX) Preferred Dividend Payments (2014 - 2026) Analysis & Trends
Jaguar Health (JAGX) has 6 years of Preferred Dividend Payments data on file, last reported at $6.1 million in Q1 2026.
- On a quarterly basis, Preferred Dividend Payments changed N/A year-over-year to $6.1 million in Q1 2026; TTM through Mar 2026 was $8.1 million, a 181.43% increase from a year earlier, with the FY2025 full-year figure at $141000.0, changed N/A from the prior year.
- Preferred Dividend Payments for Q1 2026 stood at $6.1 million, up from $1.7 million in the prior quarter.
- Over the last five years, Preferred Dividend Payments for JAGX reached as high as $6.1 million in Q1 2026 and fell as low as $6.1 million in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Nanobiotix | 1,785.82 Bn | 1,785.76 Bn | - | - |
| 2 | Akari Therapeutics | 979.03 Bn | 979.03 Bn | - | - |
| 3 | BeOne Medicines | 473.37 Bn | 468.58 Bn | 1.35 Bn | - |
| 4 | Vertex Pharmaceuticals | 123.58 Bn | 116.33 Bn | 2.59 Bn | - |
| 5 | Regeneron Pharmaceuticals | 71.54 Bn | 62.78 Bn | 3.31 Bn | - |
| 6 | Belite Bio | 62.17 Bn | 62.17 Bn | - | - |
| 7 | Argenx Se | 54.63 Bn | 49.44 Bn | 1.41 Bn | - |
| 8 | Alnylam Pharmaceuticals | 38.11 Bn | 35.10 Bn | 959.66 Mn | - |
| 9 | Revolution Medicines | 36.17 Bn | 36.17 Bn | - | - |
| 10 | Jaguar Health | 523,524.81 | -9.54 Mn | 19.11 Mn | 6.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.06 Mn |
| Dec 31, 2020 | 1.67 Mn |
| Sep 30, 2020 | 349,000.00 |
| Jun 30, 2020 | 856,000.00 |
| Mar 31, 2020 | 480,000.00 |
| Dec 31, 2019 | 3.99 Mn |
| Sep 30, 2019 | 252,000.00 |
| Mar 31, 2019 | 995,000.00 |
| Sep 30, 2018 | 1.99 Mn |
| Jun 30, 2018 | -995,000.00 |
| Mar 31, 2018 | 995,000.00 |
| Jun 30, 2015 | 159,288.00 |
| Mar 31, 2015 | 187,086.00 |
| Dec 31, 2014 | 180,832.00 |
| Sep 30, 2014 | 180,832.00 |
| Jun 30, 2014 | 205,163.00 |
| Mar 31, 2014 | 79,846.00 |